Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liquid Valine and Isoleucine in Maple Syrup Urine Disease
Sponsor: Meta Healthcare Ltd
Summary
This is a prospective, observational research study in 5 children with Maple Syrup Urine Disease (MSUD). Subjects who are currently taking a valine and isoleucine supplement for MSUD will be recruited for a 56 day trial, of a new ready-to-use valine supplement and a new ready-to-use isoleucine supplement, to evaluate the tolerability and acceptability of the study products compared with their usual products.
Official title: Valine 50mg/ml and Isoleucine 25mg/ml Oral Solutions for Maple Syrup Urine Disease (MSUD) - Acceptability and Tolerance Study
Key Details
Gender
All
Age Range
12 Months - 16 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2024-10
Completion Date
2026-09
Last Updated
2024-09-03
Healthy Volunteers
No
Conditions
Interventions
Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml)
Subjects will take valine oral solution (50mg/ml) in place of usual powdered valine supplement for 28 days. Subjects will then take isoleucine oral solution (25mg/ml) in place of their usual powdered isoleucine supplement for 28 days.